arrow
E

Edmarie Guzmán-Vélez

MGH
H指数:22
被引数:2,346

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial

烟酰胺核糖对长新冠NAD+水平、认知功能及症状恢复的影响:一项随机对照试验

2025-11-120
OAAI
Association among cardiorespiratory fitness, plasma biomarkers of pathology and astrocyte reactivity, and cognition in autosomal-dominant Alzheimer's disease

常染色体显性遗传阿尔茨海默病中,心肺适能、病理学血浆生物标志物和星形胶质细胞反应性,以及认知能力之间的关联

2025-05-270
PRE
Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment
2025-01-150
OA
Cortical thickness across the lifespan in a Colombian cohort with autosomal-dominant Alzheimer's disease: A cross-sectional study
2021-09-145
OA
Neuroticism is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease

在常染色体显性阿尔茨海默氏病的认知未受损个体中,神经质与Tau病理学相关

2021-08-1711
OAAI
Global Cardiovascular Risk Profile and Cerebrovascular Abnormalities in Presymptomatic Individuals with CADASIL or Autosomal Dominant Alzheimer's Disease

患有CADASIL或常染色体显性阿尔茨海默病的症状前个体的整体心血管风险特征和脑血管异常

2021-07-215
OAAI
Associations between subregional thalamic volume and brain pathology in autosomal dominant Alzheimer's disease

常染色体显性阿尔茨海默氏病的分区域丘脑体积与脑病理之间的关联

2021-05-1014
OAAI
The impact of COVID-19 on the well-being and cognition of older adults living in the United States and Latin America

新型冠状病毒肺炎对居住在美国和拉丁美洲的老年人的幸福感和认知的影响

2021-05-0122
OAAI
Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non-demented individuals with autosomal-dominant Alzheimer's disease
2021-02-0114
OA
Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker study

常染色体显性阿尔茨海默病的纵向淀粉样蛋白和tau积累: 来自哥伦比亚-波士顿 (COLBOS) 生物标志物研究的发现

2021-01-1534
OAAI
PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer's disease-causing Presenilin-1 E280A mutation carriers
2021-01-0112
OAAI
Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study
2020-10-1318
OAAI
The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer's disease
2020-09-1012
OAAI